Azitra (AZTR) had the highest return between October 1, 2022 and December 31, 2023 by a US stock, returning 3,285,614.3%.
| ASSET | DATE | % RETURN |
|---|---|---|
Azitra (AZTR) | 10/1/2022 - 12/31/2023 | 3,285,614.29% |
MKDWELL Tech Inc Ordinary Share (MKDW) | 10/1/2022 - 12/31/2023 | 2,812,400% |
Agape ATP Corporation Common Stock (ATPC) | 10/1/2022 - 12/31/2023 | 318,603.24% |
Foremost Lithium Resource & Technology Ltd Common stock (FMST) | 10/1/2022 - 12/31/2023 | 71,328.57% |
Clean Energy Technologies, Inc Common Stock (CETY) | 10/1/2022 - 12/31/2023 | 17,928.85% |
SS Innovations International Inc Common Stock (SSII) | 10/1/2022 - 12/31/2023 | 16,377.27% |
Prestige Wealth (AURE) | 10/1/2022 - 12/31/2023 | 4,229.9% |
Cabaletta Bio (CABA) | 10/1/2022 - 12/31/2023 | 3,339.39% |
JIN MEDICAL INTERNATIONAL LTD Ordinary Shares (ZJYL) | 10/1/2022 - 12/31/2023 | 3,000.63% |
Castellum (CTM) | 10/1/2022 - 12/31/2023 | 2,850.5% |
Nukkleus (NUKK) | 10/1/2022 - 12/31/2023 | 2,810.05% |
Soleno Therapeutics (SLNO) | 10/1/2022 - 12/31/2023 | 2,200% |
American Coastal Insurance (ACIC) | 10/1/2022 - 12/31/2023 | 1,318.02% |
Tian Ruixiang (TIRX) | 10/1/2022 - 12/31/2023 | 995.24% |
MoonLake Immunotherapeutics (MLTX) | 10/1/2022 - 12/31/2023 | 654.88% |
Immunovant (IMVT) | 10/1/2022 - 12/31/2023 | 643.03% |
Applied Opt (AAOI) | 10/1/2022 - 12/31/2023 | 600% |
ENDRA Life Sciences (NDRA) | 10/1/2022 - 12/31/2023 | 594.37% |
Viking Therapeutics (VKTX) | 10/1/2022 - 12/31/2023 | 574.28% |
Biohaven Pharmaceutical (BHVN) | 10/1/2022 - 12/31/2023 | 569.8% |
Direct Digital (DRCT) | 10/1/2022 - 12/31/2023 | 535.9% |
QXO (QXO) | 10/1/2022 - 12/31/2023 | 521.05% |
Limbach (LMB) | 10/1/2022 - 12/31/2023 | 470.51% |
Abercrombie & Fitch (ANF) | 10/1/2022 - 12/31/2023 | 453.45% |
Gyre Therapeutics (GYRE) | 10/1/2022 - 12/31/2023 | 453.32% |
